510 related articles for article (PubMed ID: 25414194)
1. Endothelial TWIST1 promotes pathological ocular angiogenesis.
Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
[TBL] [Abstract][Full Text] [Related]
2. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
3. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.
Liu CH; Sun Y; Li J; Gong Y; Tian KT; Evans LP; Morss PC; Fredrick TW; Saba NJ; Chen J
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12163-8. PubMed ID: 26374840
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
5. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
6. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
8. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
9. SNAI1, an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization.
Sun JX; Chang TF; Li MH; Sun LJ; Yan XC; Yang ZY; Liu Y; Xu WQ; Lv Y; Su JB; Liang L; Han H; Dou GR; Wang YS
Angiogenesis; 2018 Aug; 21(3):635-652. PubMed ID: 29675549
[TBL] [Abstract][Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
[TBL] [Abstract][Full Text] [Related]
15. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of
Zhang L; Zhang SS; Wang KF; Li YH; Xu HJ; Sun KX; Ma S; Leng HM; Chen SZ; Jia WJ; Zhu XJ; Li J
Zool Res; 2022 Jan; 43(1):64-74. PubMed ID: 34845879
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin-RAMP2 system is crucially involved in retinal angiogenesis.
Iesato Y; Toriyama Y; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yoshizawa T; Koyama T; Uetake R; Yang L; Yamauchi A; Tanaka M; Igarashi K; Murata T; Shindo T
Am J Pathol; 2013 Jun; 182(6):2380-90. PubMed ID: 23562442
[TBL] [Abstract][Full Text] [Related]
18. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 Deletion Impairs Retinal Endothelial Cell Migration Through Downregulation of VEGF-A/VEGFR-2 and MMP14.
Lin Y; Li L; Liu J; Zhao X; Ye J; Reinach PS; Qu J; Yan D
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5431-5440. PubMed ID: 30452596
[TBL] [Abstract][Full Text] [Related]
20. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
